Acadia Pharmaceuticals Inc.

This study continues testing a nasal spray called carbetocin for people with Prader-Willi syndrome who struggle with extreme, constant hunger. It's for 160 participants who finished a previous 12-week trial to check long-term safety and side effects. The spray is given three time…

This study continues testing ACP-204 for psychosis symptoms in people with Lewy body dementia for one full year. It's for 126 patients who already completed the previous trial and want to keep taking the medication. The main goal is to check how safe the drug is over the long ter…

This study aims to check the long-term safety of a drug called ACP-204 for people with Alzheimer's disease who experience psychosis, like hallucinations or delusions. It's a 52-week follow-up for 752 adults who completed a previous trial. The main goal is to see how well people t…

This study is testing whether a carbetocin nasal spray can reduce the constant, extreme hunger (hyperphagia) that is the most challenging symptom of Prader-Willi syndrome (PWS). About 170 participants, aged 5 to 30, will use the spray or a placebo for 12 weeks. The main goal is t…